We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microarrays Uncover Connection Between Genomic Errors and Neurologic Disorders

By Labmedica staff writers
Posted on 04 Feb 2008
Microarrays are providing the design capabilities, sensitivity, and resolution, which enable scientists to discover a mechanism of genomic errors associated with certain diseases.

Genomic copy number changes or translocations occurring during cell division are associated with a wide range of diseases especially developmental and neurologic disorders such as Alzheimer's, Parkinson's, and Potocki-Lupski Syndrome. More...
When the DNA addition or deletion occurs in the wrong place, another genomic-based disorder such as Pelizaeus-Merzbacher disease (PMD) can occur. PMD is a progressive degenerative disorder of the central nervous system in which motor abilities and intellectual function deteriorate. This X-chromosome-linked neurodevelopment disorder affects males and can have particularly devastating consequences.

Scientists at Baylor College of Medicine (BCM; Houston, TX, USA), used their own SurePrint in situ synthesis platform together with Agilent (Santa Clara, CA, USA) microarrays to observe the unique way that DNA additions or deletions introduced in genes during cell division were associated the diseases. The mechanism for human genomic disorders in which segments of DNA are added or deleted during replication is called replication Fork Stalling and Template Switching (FoSTes).

Jennifer Lee, Ph.D., a member of the Baylor team, was studying PMD and found genomic changes that previous theory about DNA recombination did not explain. In some places, extra genetic material was found in the middle of a different duplication.

"The Agilent microarrays were essential in enabling us to elucidate this novel mechanism,” said BCM's James R. Lupski, M.D., Ph.D., professor of molecular and human genetics, and senior investigator in this project. Prof. Lupski pioneered the emerging field of copy number variation (CNV) in the early 1990s in the quest to understand genetic variation and the multiple molecular mechanisms for disease. Now, he and his colleagues have discovered that the DNA replication process can stall, and sometimes, switch to a different "template” rather than restarting in the same place. In addition to disease research, according to Dr. Lupski, the FoSTeS mechanism could also play an important role in studies investigating human evolution.

The findings were published in the January 2007 issue of the journal Cell.


Related Links:
Baylor College of Medicine
Agilent

Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.